UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The emerging role of cell-free DNA as a molecular marker for cancer management

Biomolecular detection and quantification, 2019-03, Vol.17, p.100087, Article 100087

2019

Volltextzugriff (PDF)

Serial profiling of cell-free DNA and nucleosome histone modifications in cell cultures

Scientific reports, 2021-05, Vol.11 (1), p.9460-9460, Article 9460

2021

Volltextzugriff (PDF)

Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis

British journal of cancer, 2017-04, Vol.116 (8), p.1037-1045

2017

Volltextzugriff (PDF)

Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms

International journal of molecular sciences, 2020-10, Vol.21 (21), p.8062

2020

Volltextzugriff (PDF)

Comparison of methods for the isolation of cell-free DNA from cell culture supernatant

Tumor biology, 2020-04, Vol.42 (4), p.1010428320916314-1010428320916314

2020

Volltextzugriff (PDF)

Towards systematic nomenclature for cell-free DNA

Human genetics, 2021-04, Vol.140 (4), p.565-578

2021

Volltextzugriff (PDF)

Comparison of methods for the quantification of cell-free DNA isolated from cell culture supernatant

Tumor biology, 2019-08, Vol.41 (8), p.1010428319866369-1010428319866369

2019

Volltextzugriff (PDF)

Immune checkpoint therapy for pancreatic cancer

World journal of gastroenterology : WJG, 2016-11, Vol.22 (43), p.9457-9476

2016

Volltextzugriff (PDF)

Aggrecan: a new biomarker for acute type A aortic dissection

Scientific reports, 2021-05, Vol.11 (1), p.10371-10371, Article 10371

2021

Volltextzugriff (PDF)

Time courses of HMGB1 and other inflammatory markers after generalized convulsive seizures

Epilepsy research, 2020-05, Vol.162, p.106301-106301, Article 106301

2020

Volltextzugriff (PDF)

Clinically Meaningful Use of Blood Tumor Markers in Oncology

BioMed research international, 2016-01, Vol.2016 (2016), p.1-10

2016

Volltextzugriff (PDF)

Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases

Nature medicine, 2010-08, Vol.16 (8), p.887-896

2010

Volltextzugriff (PDF)

MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels

PloS one, 2011-09, Vol.6 (9), p.e25787-e25787

2011

Volltextzugriff (PDF)

Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer

Oncoimmunology, 2017-05, Vol.6 (5), p.e1310358-e1310358

2017

Volltextzugriff (PDF)

Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study

Clinical chemistry (Baltimore, Md.), 2017-07, Vol.63 (7), p.1288-1296

2017

Volltextzugriff (PDF)

Krebsfrüherkennung – das große Versprechen: Pan-Cancer-Screening mittels Plasma-ctDNA

Trillium Diagnostik, 2021-09, Vol.19 (3), p.234-236

Holdenrieder, Stefan

2021

Volltextzugriff (PDF)

The Clinical Utility of Droplet Digital PCR for Profiling Circulating Tumor DNA in Breast Cancer Patients

Diagnostics (Basel), 2022-12, Vol.12 (12), p.3042

2022

Volltextzugriff (PDF)

Bi-allelic Mutations in LSS, Encoding Lanosterol Synthase, Cause Autosomal-Recessive Hypotrichosis Simplex

American journal of human genetics, 2018-11, Vol.103 (5), p.777-785

2018

Volltextzugriff (PDF)

The International Collaboration for Cancer Classification and Research

International journal of cancer, 2021-02, Vol.148 (3), p.560-571

2021

Volltextzugriff (PDF)

Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases

Diagnostics (Basel), 2015-06, Vol.5 (2), p.219-253

2015

Volltextzugriff (PDF)

Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma

International journal of urology, 2012-11, Vol.19 (11), p.1017-1025

2012

Volltextzugriff (PDF)

Histone Methylation Marks on Circulating Nucleosomes as Novel Blood-Based Biomarker in Colorectal Cancer

International journal of molecular sciences, 2015-12, Vol.16 (12), p.29654-29662

2015

Volltextzugriff (PDF)

Longitudinal Evaluation of AFP and CEA External Proficiency Testing Reveals Need for Method Harmonization

Diagnostics (Basel), 2023-06, Vol.13 (12), p.2019

2023

Volltextzugriff (PDF)

Loss of Key EMT-Regulating miRNAs Highlight the Role of ZEB1 in EGFR Tyrosine Kinase Inhibitor-Resistant NSCLC

International journal of molecular sciences, 2023-09, Vol.24 (19), p.14742

2023

Volltextzugriff (PDF)

Pan-cancer screening by circulating tumor DNA (ctDNA) – recent breakthroughs and chronic pitfalls

Journal of laboratory medicine, 2022-08, Vol.46 (4), p.247-253

2022

Volltextzugriff (PDF)

1 – 25 von 339

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(315)
Mit Volltextzugriff
(287)

Publikationsform

Artikel
(335)
Buchkapitel
(4)

Sprache

Englisch
(323)
Japanisch
(28)
Deutsch
(20)
Chinesisch
(5)
Spanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The emerging role of cell-free DNA as a molecular marker for cancer management

Serial profiling of cell-free DNA and nucleosome histone modifications in cell cultures

Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis

Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms

Comparison of methods for the isolation of cell-free DNA from cell culture supernatant

Towards systematic nomenclature for cell-free DNA

Comparison of methods for the quantification of cell-free DNA isolated from cell culture supernatant

Immune checkpoint therapy for pancreatic cancer

Aggrecan: a new biomarker for acute type A aortic dissection

Time courses of HMGB1 and other inflammatory markers after generalized convulsive seizures

Clinically Meaningful Use of Blood Tumor Markers in Oncology

Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases

MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels

Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer

Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study

Krebsfrüherkennung – das große Versprechen: Pan-Cancer-Screening mittels Plasma-ctDNA

The Clinical Utility of Droplet Digital PCR for Profiling Circulating Tumor DNA in Breast Cancer Patients

Bi-allelic Mutations in LSS, Encoding Lanosterol Synthase, Cause Autosomal-Recessive Hypotrichosis Simplex

The International Collaboration for Cancer Classification and Research

Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases

Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma

Histone Methylation Marks on Circulating Nucleosomes as Novel Blood-Based Biomarker in Colorectal Cancer

Longitudinal Evaluation of AFP and CEA External Proficiency Testing Reveals Need for Method Harmonization

Loss of Key EMT-Regulating miRNAs Highlight the Role of ZEB1 in EGFR Tyrosine Kinase Inhibitor-Resistant NSCLC

Pan-cancer screening by circulating tumor DNA (ctDNA) – recent breakthroughs and chronic pitfalls

Suchergebnisse filtern